SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535264-17-000028
Filing Date
2017-02-10
Accepted
2017-02-10 16:56:17
Documents
1
Group Members
ADAM C. STETTNERAUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS, LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.SSCAYMAN, LLC

Document Format Files

Seq Description Document Type Size
1 ESSA 13G essa13gt.txt SC 13G 7493
  Complete submission text file 0001535264-17-000028.txt   9439
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2123196670
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-88939 | Film No.: 17594348
SIC: 2834 Pharmaceutical Preparations